Muhammad Maqbool, MD
Interventional Pain Medicine · Tulsa, OKNPI 1992018253
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (38.0%), grants and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 88.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $3,989 and has fallen 81.9% since, to $720 in 2025. Among interventional pain medicine clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 55 payments — averaging $142.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- SPR Therapeutics, Inc$513
- Abbott$101
- Collegium Pharmaceutical, Inc.$99
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$35
- Boston Scientific$34
- plus $143 from 6 others
What the payments were for
- Grants$2,50032%
- Travel & lodging$2,97338%
- Food & beverage$2,34130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 33 | $6,890 |
| SPR Therapeutics, Inc | 7 | $513 |
| Abbott | 1 | $101 |
| Collegium Pharmaceutical, Inc. | 5 | $99 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| Boston Scientific | 1 | $34 |
| Vertex | 1 | $31 |
| Stryker | 1 | $29 |
| Averitas Pharma Inc. | 1 | $24 |
| Baxter Healthcare | 1 | $23 |
| Globus Medical | 1 | $20 |
| Valinor Pharma, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$2,683
- SYNCHROMEDII$2,500
- VANTA ADAPTIVESTIM$1,022
- SPRINT PNS System$378
- ETERNA$101
How this compares
$7,815 in reported general payments places this provider in the 90th percentile of 27 interventional pain medicine providers in Oklahoma.
See all interventional pain medicine providers in Oklahoma →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 15 | $2,505 |
| Gabapentin | 130 | $1,989 |
| Pregabalin | 57 | $1,782 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 47 | $1,059 |
| Baclofen | 45 | $641 |
| Celecoxib | 11 | $635 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $415 |
| Cyclobenzaprine Hcl | 25 | $362 |
| Tramadol Hcl | 26 | $293 |
| Levetiracetam | 28 | $247 |
| Oxycodone Hcl | 18 | $243 |
| Duloxetine Hcl | 22 | $135 |
| Meloxicam | 25 | $99 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Tulsa
- Samuel KorbeTulsa$7K
- Frank HacklTulsa$2K
- Bhadresh BhaktaTulsa$1K
- Gerald HaleTulsa$1K
- Brandon ValantineOklahoma City$9K
- Amer NouhEdmond$8K
- Justin PorterOklahoma City$8K
- Joshua WoolardEdmond$7K
- Michael McLaughlinMoore$7K
- Steve RandallMidwest City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.